Warning
Graviti Pharmaceuticals Private Limited Recalls Furosemide Tablets
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0293-2026Drug / Pharmaceutical
Graviti Pharmaceuticals Private Limited Recalls Furosemide Tablets
Graviti Pharmaceuticals Private Limited · Class II — Moderate Risk
Product Description
Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., East Brunswick, NJ 08816, Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, India, NDC 64980-563-10.
Reason for Recall
Presence of Foreign Substance
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
U.S. Nationwide
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
The FDA classified this recall as Class II, indicating the pharmaceutical product may cause temporary health problems or poses a slight threat of a serious nature. Graviti Pharmaceuticals Private Limited initiated the recall on January 10, 2026 affecting 4212 bottles. Presence of Foreign Substance. The product was distributed in U.S. Nationwide. Consumers should check their purchases and discontinue use of any affected product. Contact Graviti Pharmaceuticals Private Limited for further instructions.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medical Product Contamination.